Avid Bioservices to Participate at Upcoming Investor Conferences

On September 2, 2021 Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, reported that the company will participate in two upcoming investor conferences (Press release, Avid Bioservices, SEP 2, 2021, View Source [SID1234587169]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the company’s participation are as follows:

Morgan Stanley 19th Annual Global Healthcare Conference
Details: Avid management will participate in a fireside chat and 1-on-1 meetings
Conference Dates: September 9-10 and 13-15, 2021
Fireside Chat Timing: 2:45 – 3:15 p.m. Eastern on Thursday, September 9, 2021
Format: Virtual conference; webcast available
HC Wainwright 23rd Annual Global Investment Conference
Details: Avid management will deliver a corporate presentation and participate in 1-on-1 meetings
Conference Dates: September 13-15, 2021
Presentation Timing: Available online at 7:00 a.m. Eastern on Monday, September 13, 2021
Format: Virtual conference
To listen to the live webcast of the Morgan Stanley fireside chat, or access the archived webcast, please visit: View Source